RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,518 | -11.2% | 93,072 | +6.0% | 0.00% | – |
| Q2 2023 | $113,257 | +2.7% | 87,796 | +5.1% | 0.00% | – |
| Q1 2023 | $110,277 | -56.6% | 83,543 | -50.7% | 0.00% | – |
| Q4 2022 | $254,248 | -95.8% | 169,498 | -96.7% | 0.00% | -100.0% |
| Q3 2022 | $6,099,000 | +4.6% | 5,168,413 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $5,830,000 | -62.2% | 5,159,866 | -0.0% | 0.00% | -50.0% |
| Q1 2022 | $15,435,000 | +12.8% | 5,161,717 | -0.0% | 0.00% | +33.3% |
| Q4 2021 | $13,680,000 | -27.3% | 5,162,199 | -0.4% | 0.00% | -40.0% |
| Q3 2021 | $18,807,000 | -16.1% | 5,180,947 | +0.3% | 0.01% | -16.7% |
| Q2 2021 | $22,415,000 | +27.5% | 5,164,760 | +0.5% | 0.01% | +20.0% |
| Q1 2021 | $17,582,000 | -2.0% | 5,140,933 | +0.3% | 0.01% | 0.0% |
| Q4 2020 | $17,943,000 | +49.2% | 5,126,593 | +2.3% | 0.01% | +25.0% |
| Q3 2020 | $12,029,000 | +31.2% | 5,012,235 | +0.0% | 0.00% | +33.3% |
| Q2 2020 | $9,171,000 | +17.3% | 5,011,761 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,818,000 | -26.9% | 5,011,696 | +0.2% | 0.00% | 0.0% |
| Q4 2019 | $10,700,000 | +14.4% | 5,000,131 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $9,350,000 | -28.4% | 5,000,131 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $13,050,000 | +31729.3% | 5,000,131 | +42691.0% | 0.00% | – |
| Q1 2018 | $41,000 | 0.0% | 11,685 | +10.0% | 0.00% | – |
| Q4 2017 | $41,000 | +41.4% | 10,624 | -8.4% | 0.00% | – |
| Q3 2017 | $29,000 | -3.3% | 11,596 | +4.3% | 0.00% | – |
| Q2 2017 | $30,000 | -63.0% | 11,114 | -69.5% | 0.00% | – |
| Q2 2016 | $81,000 | -28.9% | 36,411 | -33.5% | 0.00% | – |
| Q1 2016 | $114,000 | -59.6% | 54,734 | -41.1% | 0.00% | – |
| Q4 2015 | $282,000 | +25.3% | 92,994 | +1.8% | 0.00% | – |
| Q3 2015 | $225,000 | -21.9% | 91,383 | +1.9% | 0.00% | – |
| Q2 2015 | $288,000 | +50.0% | 89,684 | +67.0% | 0.00% | – |
| Q1 2015 | $192,000 | +34.3% | 53,705 | -14.8% | 0.00% | – |
| Q4 2014 | $143,000 | +23.3% | 63,058 | +5.4% | 0.00% | – |
| Q3 2014 | $116,000 | -43.7% | 59,837 | +5.7% | 0.00% | – |
| Q2 2014 | $206,000 | -7.2% | 56,632 | -0.9% | 0.00% | – |
| Q1 2014 | $222,000 | +303.6% | 57,127 | +194.0% | 0.00% | – |
| Q4 2013 | $55,000 | -14.1% | 19,432 | +8.0% | 0.00% | – |
| Q3 2013 | $64,000 | +18.5% | 17,986 | +11.4% | 0.00% | – |
| Q2 2013 | $54,000 | – | 16,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |